Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2025-09-18 Report Publication Anno…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Information sur les résultats du 1er semestre 2025
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 6,500 characters) from Novacyt S.A. stating that they will publish their unaudited financial results for the first half of 2025 on a future date (September 30, 2025). It does not contain the actual financial report, but rather serves as a notification of the upcoming release. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-09-18 French
Appointment of Joint Corporate Broker
Board/Management Information Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from Novacyt S.A. regarding the appointment of a new joint corporate broker (Singer Capital Markets). This type of corporate announcement regarding professional service providers or administrative changes does not fit into specific categories like M&A, financial results, or director dealings. Therefore, it is classified as a general regulatory filing.
2025-09-15 English
Nomination d'un co-courtier pour l’entreprise
Board/Management Information Classification · 100% confidence The document is a corporate announcement regarding the appointment of a new co-broker (Singer Capital Markets) for the company. This type of announcement relates to corporate financing and market advisory relationships, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A, Board changes, or Share issues.
2025-09-15 French
Resolution re. Lab 21 HSE Prosecution
Legal Proceedings Report Classification · 100% confidence The document is an official announcement from Novacyt S.A. regarding the conclusion of a legal prosecution (Health and Safety Executive case) involving a subsidiary. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. Since it details the outcome of a specific legal proceeding/lawsuit, it falls under the 'Legal Proceedings Report' category.
2025-09-12 English
Décision concernant les poursuites engagées par le HSE contre Lab 21
Legal Proceedings Report Classification · 100% confidence The document is an official announcement from Novacyt S.A. regarding the conclusion of legal proceedings (prosecution) initiated by the Health and Safety Executive (HSE) against its subsidiary, Lab 21. It details the court's decision, the fine imposed, and the impact on the company's financial position. Since this is a specific update on a legal matter/lawsuit, it falls under the 'Legal Proceedings Report' category.
2025-09-12 French
Liquidity Agreement Monthly Update and TVR
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Novacyt S.A. regarding a monthly update on its liquidity agreement (share buybacks/sales) and total voting rights. This type of disclosure, specifically detailing transactions in own shares and updates on voting rights, falls under the 'Transaction in Own Shares' category as it reports the company's activity in its own equity.
2025-09-01 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.